Sign up for newborn stem cell news and more.
You're on the list!
Check your inbox for the latest news
Sign up, get your kit in the mail, bring it to your delivery, and call our courier to pick it up when it's ready. We'll take care of the rest.
Free Info Kit Ready to EnrollGet Answers from a Specialist
Call us at 1-888-932-6568 or schedule a call by providing your contact info and availability preference below.
To help us best serve you, tell us a little bit more about yourself.
A representative will contact you shortly.
The purpose of processing is to separate stem cells from the rest of the cord blood, producing a sample that can be used safely and successfully.
CBR uses AXP® processing technology when separating out the cell concentration rich in stem cells from your family's cord blood collection for ultimate precision. The AXP AutoXpress® Platform* is FDA-cleared and automated to assist with cGMP (current good manufacturing practice) and cGTP (current good tissue practice) compliance.
Additional resources comparing cord blood processing methods
AXPReference: Rubinstein P. Cord blood banking for clinical transplantation. Bone Marrow Transplantation. 2009;44:635-642
Reference: Marzan AJ, Wilson C, Wheeler-Beunger J, Brown KS, Shamonki JM. Impact of Cord Blood Anticoagulant on Cell Recovery Following Volume and Red Blood Cell Reduction. Data presented at the AABB Meeting, 2020 October, virtual.
HespanReference: Basford C, Forraz N, Habibollah S, Hanger K, McGuckin CP. Umbilical cord blood processing using Prepacyte-CB increases haematopoietic progenitor cell availability over conventional Hetastarch separation. Cell Prolif. 2009;42(6):751-761. doi:10.1111/j.1365-2184.2009.00646.x
Reference: Basford C, Forraz N, Habibollah S, Hanger K, McGuckin CP. Umbilical cord blood processing using Prepacyte-CB increases haematopoietic progenitor cell availability over conventional Hetastarch separation. Cell Prolif. 2009;42(6):751-761. doi:10.1111/j.1365-2184.2009.00646.x